Central Lakes Medical

» Therapeutic Enzymes

  • Acid aGlucosidase
  • Activation of FIX Zymogen
  • Additional Safety Concerns
  • Adverse Reactions and Warnings - 2 3
  • Advisory Committee Preparation and Execution
  • Alteplase
  • Ancrod
  • Ancrod Development
  • Antithrombotic Activity of APC
  • Antithrombotic Mechanism
  • APC Mechanism and Sepsis
  • APC Mechanisms of Action
  • At
  • Biochemical Aspects
  • Biochemical Characteristics
  • Biochemical Function in GAG Metabolism
  • Biochemical Properties - 2
  • Biochemistry
  • Biochemistry and Genetics of Recombinant aLIduronidase - 2
  • C
  • Catalytic Activity
  • Catalytic Mechanism
  • Cell Banking and Stability of the Cell Line
  • Cell Culture and Perfusion Process
  • Cell Line Identification
  • Characterization of Protein and Carbohydrate
  • Clinical Deficiency of aLIduronidase and MPS I
  • Clinical Development of Drotrecogin Alfa Activated for Severe Sepsis
  • Clinical Evaluation 11571 Preclinical Studies
  • Clinical Safety
  • Clinical Studies - 2
  • Clinical Trials
  • Conclusions - 2 3
  • Contents - 2 3 4 5 6 7 8 9 10 11 12 13
  • Contributors
  • Determination of Activity
  • Development of an rFIX Production Line
  • Development of Ceredase
  • Development of rFVIIa as a Universal Hemostatic Agent
  • Development of rhAPC
  • Developmental History of the Enzyme 1051 Preclinical Development
  • Discovery of Correction In Vitro Uptake and Treatment of MPS I
  • Nase I in NonCF Respiratory Diseases
  • Nase I in Wound Healing and Cancer
  • Early Attempts at Therapy
  • Early Production of rhIDU
  • Early Treatments
  • Efficacy in Models of Ischemic Injury
  • Enzyme Composition Synthesis and Biochemical Action 12211 Protein and Gene Sequence and Structure
  • Figure 101 - 2
  • Figure 102
  • Figure 103 - 2
  • Figure 104
  • Figure 105
  • Figure 106
  • Figure 111
  • Figure 112 - 2
  • Figure 113
  • Figure
  • Figure 121
  • Figure 122
  • Figure 123
  • Figure 124 - 2
  • Figure 131
  • Figure 132
  • Figure 134
  • Figure 135 3 4 5
  • Figure 22 6 7 8 9 10 11 12 13 14 15 16
  • Figure 53 17 18 19 20 21 22 23 24 25
  • Figure 77
  • Figure 811 26
  • FIX Modification
  • Formulation and Administration Aspects
  • FVII Deficiency
  • Gaucher Disease
  • Gene Therapy for Hemophilia B
  • Gj Vc
  • Gj Vi
  • Glanzmanns Thrombasthenia
  • Hemophilia Patients with Inhibitors
  • High Purity pdFIX Products
  • Hyaluronidase
  • Indications for which Factor VIIa is Approved
  • Info - 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
  • Intracellular Trafficking and Uptake Via M6PR
  • Introduction - 2
  • Introduction and Overview 3 4 5
  • K
  • Manifestations of the Spectrum of Mps I Disease
  • Manufacture and Composition - 2 3
  • Manufacturing Process
  • Mechanism of Action of rFVIIa
  • Mechanistic Observations from the Clinical Experience
  • Molecular Basis
  • Mutations in aLlduronidase in MPS I
  • N - 2
  • N N
  • NLinked Carbohydrate Structure
  • NLinked Glycosylation
  • Nonresponders and Inhibition of DNase I by Actin
  • Nonviral Vectors
  • OLinked Glycosylation
  • On O
  • Pancreatin
  • Pathophysiology of MPS I
  • Pharmacokinetics in Patients
  • Polymorphisms
  • Preface
  • Production and Stability of rhDNase I
  • Production of Acid aGlucosidase for Therapeutic
  • Production of Streptokinase
  • Prospects
  • Protein Domain Structure of FIX
  • Purification
  • Purification and Characterization of Recombinant Produced Human APC
  • Purification of Highly Purified High Uptake rhIDU
  • Purification of rFIX
  • Purity and Safety
  • Q
  • Quality Control Evaluations
  • Rationale and Clinical Results
  • Rationale for Enzyme Therapy in MPS I
  • Reductions in Measures of Storage
  • References - 2 3 4 5 6
  • Regulatory Approval
  • Regulatory Strategies and Challenges with Surrogate Endpoints
  • Results from Finalized Trials Outside the Current Indication
  • Reteplase
  • RFIX Biochemical Properties and Characterization
  • RFIX Formulation
  • RFIX Production Cell Line
  • RhAPC Derivatives
  • Role of Protein C Pathway in Sepsis
  • S
  • S61
  • Safety
  • Shiprec
  • Sources of Urokinase
  • Steps to Increase Safety of Blood Derived Clotting Factor Products
  • Streptokinase
  • Studies of ERT in Canine MPS I
  • Study Results in Reducing Lysosomal Storage
  • Study Results in the Clinical Manifestations
  • Study Results in the Primary Endpoints
  • Summary and Conclusions
  • Superoxide Dismutase
  • Table - 2 3 4 5 6 7 8 9
  • Tenecteplase
  • Testicular Type Hyaluronidases
  • Therapeutic Applications - 2 3
  • Therapeutic Efficacy
  • Therapeutic Hyaluronidases
  • Therapeutic Rationale for Sepsis 4431 Sepsis Pathophysiology
  • Therapeutic Uses
  • Three Dimensional Structure of FVIIa and its Relation to Function
  • Treatment of Hemophilia B
  • University of Limerick Limerick Ireland
  • Urokinase
  • Use of Clinical Endpoints in a Novel Disease Target
  • Viral Vectors for Hemophilia B Gene Therapy
  • X
  • Ynsgkleefvqgnlerecmeekcsfeearevfentertte Fwkqyv Dgdq 5
  • Eaftlets Structures

    Eaftlets Structures

  • Reviews

    • How to Reverse Testicular Atrophy
    • Scabies Relief in 24 hours or less
    • Home Remedies Hives Urticaria
    • How To Stop Hair Loss Regrow It
    • How To Remove Your Warts Skin Tags
    • Sarcoidosis Remission Aden Protocol
    • Proven Method to Cure Shingles
    • How To Stop Toothache in 10 Minutes
    • Keratosis Pilaris Natural Cure
    • Expert Tips On How To Give
  • Popular Articles

    • Trichoepithelioma Eyelid Diseases
    • Direction Flow In Color Doppler
    • Disinfection Transfer Set during
    • Addressing Consultee Difficulties
    • The Four Types Mental Health
    • Ineffective Breathing Pattern
    • Tee Echocarigraphy Echocardiography
    • Treatment Intractable Bladder
    • The Pathogenic Potential S Aureus
    • The Measurement Fluorescence
    • Tailed Bacteriophage Structure
    • Motor Neurons Head Neck Muscles
    • Organisation Synapses Nervous
    • Excluding Nonspecific Labeled
    • Estimation microbial numbers
  • Categories

    • Mosaic Virus
    • Home Healthcare
    • Pediatric Nursing
    • Gynaecology
    • Medical Physiology
    • School Psychology
    • Insects
    • Garden Ferns
    • Dose Finding
    • Eyelid Diseases
    • Cardiology
    • Gastric Cancer
    • Neurosurgery
    • Urinary Tract
    • Retinal Disease
    • Food Safety
    • Dermatologic Diseases
    • Hematopoiesis
    • Dictyostelium Discoideum
    • Kinetic Mechanism
    • Anti Inflammatory
    • Forensic Medicine
    • Analytical Methods
    • Innate Immunity
    • Prostate Cancer
    • Parkinson Disease
    • Echocardiography
    • Flavouring Substances
    • Drosophila Melanogaster
    • Drugs Abuse

About | Contact | Write For Us | Shop | Privacy Policy | Resources